title: Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
authors.forename: A
authors.initials: A
authors.lastname: Alavi
authors.forename: C A
authors.initials: CA
authors.lastname: Buchpiguel
authors.forename: A
authors.initials: A
authors.lastname: Loessner
mesh_terms: D002951:Citrates; D019343:Citric Acid; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005710:Gallium Radioisotopes; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging; D008223:Lymphoma / Q000000981:diagnostic imaging; D012507:Sarcoidosis / Q000000981:diagnostic imaging*; D017565:Sarcoidosis, Pulmonary / Q000000981:diagnostic imaging; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed / Q000379:methods*
chemical_list: D002951:Citrates; D005462:Fluorine Radioisotopes; D005710:Gallium Radioisotopes; D019788:Fluorodeoxyglucose F18; D019343:Citric Acid; D003847:Deoxyglucose